首页> 外文OA文献 >Role of Human Body Composition Analysis and Malnutrition Risk Questionnaire in the Assessment of Nutritional Status of Patients With Initially Diagnosed Crohn's Disease
【2h】

Role of Human Body Composition Analysis and Malnutrition Risk Questionnaire in the Assessment of Nutritional Status of Patients With Initially Diagnosed Crohn's Disease

机译:人体成分分析和营养不良风险调查问卷在初期诊断患者营养状况评估中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: This study was carried out to investigate the role and necessity of human body composition analysis in assessing the nutritional status of initially diagnosed Crohn's disease (CD) patients.Methods: A total of 47 initially diagnosed CD patients were recruited. The skeletal muscle mass index (SMI), fat-free mass index (FFMI), body fat mass, body fat percent, visceral fat area (VFA), and body cell mass were determined with the Biospace Inbody S10 composition analyzer.Results: In 47 patients with initially diagnosed CD, SMI could determine the muscular mass reduction that could not be determined by the body mass index (BMI) (35.3%), albumin (ALB) (65.6%), nutrition risk screening (NRS)2002 (25.0%), and Patient-Generated Subjective Global Assessment (PG-SGA) (55.6%). FFMI could determine the malnutrition that could not be determined by the BMI (58.8%), albumin (90.6%), NRS2002 (50.0%), and PG-SGA (55.6%). VFA in the fistulizing CD patients was significantly higher than in the stricturing and non-fistulizing, non-stricturing patients (P < 0.05). SMI and BMI had the same performance (P = 1.000) and general consistence (Kappa = 0.487, P = 0.001) in the assessment of malnutrition; SMI and ALB had different performance (P < 0.001) and inconsistence was noted (Kappa = 0.069, P = 0.489) in the assessment of malnutrition; the results of the nutrition assessment were different between SMI and NRS2002 (P = 0.002), and inconsistence was observed (Kappa = 0.190, P = 0.071). SMI and PG-SGA had the same performance in the assessment of nutrition (P = 0.143), but there was inconsistence (Kappa = 0.099, P = 0.464). FFMI and BMI had general consistence in the assessment of malnutrition (Kappa = 0.472, P < 0.001), but the positive rate determined by FFMI (85.1%) was markedly higher than that by BMI (63.8%) (P = 0.002). FFMI and ALB had different performance in the assessment of malnutrition (P < 0.001) and there was inconsistence (Kappa = −0.008, P = 0.877). FFMI and NRS2002 had the same performance in the assessment of malnutrition (P = 0.453), but the consistence was poor (Kappa = 0.286, P = 0.039). The results determined by SMI and PG-SGA were consistent (P = 0.727), but the consistence was poor (Kappa = 0.399, P = 0.006).Conclusion: Human body composition analysis can identify the patients with muscular mass reduction that cannot be identified by commonly used nutrition assessment scales/parameters. Thus, it is helpful for the assessment of disease severity and also important for the nutrition assessment in CD patients.
机译:目的:本研究进行了研究人体成分分析在评估最初诊断患者疾病(CD)患者的营养状况方面的作用和必要性。方法:招募了47名最初诊断的CD患者。用Biospace Inbody S10组成分析仪测定骨骼肌质量指数(SMI),无脂肪块(FFMI),体脂肪块,体脂百分比,内脏脂肪区(VFA)和体细胞质量。结果:在47例初始诊断的CD患者,SMI可以确定肌肉质量降低,不能通过体重指数(BMI),白蛋白(ALB)(65.6%),营养风险筛查(NRS)2002(25.0)(25.0)(25.0 %)和患者产生的主观全局评估(PG-SGA)(55.6%)。 FFMI可以确定不能通过BMI(58.8%),白蛋白(90.6%),NRS2002(50.0%)和PG-SGA(55.6%)确定的营养不良。抗钻菌CD患者的VFA显着高于狭窄和非抗瘘管,非狭窄患者(P <0.05)。 SMI和BMI在评估营养不良的评估中具有相同的性能(P = 1.000)和一般一致(Kappa = 0.487,P = 0.001); SMI和ALB具有不同的性能(P <0.001),并注意到营养不良评估中的不一致(KAPPA = 0.069,P = 0.489);营养评估的结果在SMI和NRS2002之间存在(P = 0.002),并且观察到不一致(Kappa = 0.190,P = 0.071)。 SMI和PG-SGA在营养评估中具有相同的性能(P = 0.143),但存在不一致(Kappa = 0.099,P = 0.464)。 FFMI和BMI在评估营养不良(Kappa = 0.472,P <0.001)中具有一般一致,但FFMI(85.1%)测定的阳性率明显高于BMI(63.8%)(P = 0.002)。 FFMI和ALB在评估营养不良(P <0.001)中具有不同的性能,并且不一致(Kappa = -0.008,p = 0.877)。 FFMI和NRS2002在评估营养不良(P = 0.453)方面具有相同的性能,但一致性差(Kappa = 0.286,P = 0.039)。 SMI和PG-SGA测定的结果一致(P = 0.727),但一致性差(Kappa = 0.399,P = 0.006)。结论:人体成分分析可以识别不能识别的肌肉质量减少患者通过常用的营养评估尺度/参数。因此,有助于评估疾病严重程度,对CD患者的营养评估也很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号